TEMPERA, Giampiero
 Distribuzione geografica
Continente #
NA - Nord America 1.797
EU - Europa 627
AS - Asia 356
SA - Sud America 30
AF - Africa 24
OC - Oceania 1
Totale 2.835
Nazione #
US - Stati Uniti d'America 1.784
UA - Ucraina 150
IN - India 141
SG - Singapore 133
FI - Finlandia 94
SE - Svezia 92
IT - Italia 90
DE - Germania 88
CN - Cina 81
GB - Regno Unito 60
AR - Argentina 29
TG - Togo 22
RU - Federazione Russa 14
IE - Irlanda 12
CA - Canada 11
BG - Bulgaria 6
CH - Svizzera 6
BE - Belgio 5
FR - Francia 2
MX - Messico 2
NL - Olanda 2
RS - Serbia 2
ZA - Sudafrica 2
AL - Albania 1
BR - Brasile 1
ES - Italia 1
IR - Iran 1
LT - Lituania 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 2.835
Città #
Chandler 201
Fairfield 189
Santa Clara 140
Woodbridge 131
Ashburn 116
Ann Arbor 111
Singapore 95
Princeton 78
Houston 73
Beijing 68
Plano 68
Wilmington 67
Seattle 59
Jacksonville 54
Cambridge 53
Boston 37
Millbury 31
Federal 29
Rome 29
San Paolo di Civitate 27
Helsinki 26
Andover 22
Lomé 22
Lawrence 18
Boardman 15
Bremen 12
Dublin 12
Falkenstein 11
Norwalk 11
Des Moines 10
San Diego 10
Toronto 10
Moscow 9
Dearborn 8
Bühl 7
Fasano 6
Sofia 6
Uppsala 6
Bern 5
Brussels 5
Mannheim 5
Pune 5
Falls Church 4
San Mateo 4
Buffalo 3
Kunming 3
Nürnberg 3
Southend 3
Cagliari 2
Cassino 2
Castel di Sangro 2
Como 2
Grafing 2
Leawood 2
New York 2
Silverton 2
Vigevano 2
Anápolis 1
Auckland 1
Bagheria 1
Capannelle 1
Feltre 1
Frankfurt am Main 1
Fremont 1
Gallatin 1
Gunzenhausen 1
Hebei 1
Jinan 1
Las Vegas 1
Laurel 1
London 1
Los Angeles 1
Luoyang 1
Mexico City 1
Nanjing 1
New Delhi 1
Nuremberg 1
Ottawa 1
Paris 1
Parma 1
Philadelphia 1
Qendra 1
Quzhou 1
Redmond 1
Redwood City 1
San Francisco 1
Shaoxing 1
Springfield 1
Stockholm 1
Tettnang 1
Washington 1
Xian 1
Yurovka 1
Totale 1.971
Nome #
Polyamines: fundamental characters in chemistry and biology 105
Potential anticancer application of polyamine oxidation products formed by amine oxidase: a new therapeutic approach 95
Polyketone polymer: A new support for direct enzyme immobilization 76
Cytotoxicity of spermine oxidation products to multidrug resistant melanoma M14 ADR2 cells: Sensitization by the MDL 72527 lysosomotropic compound 73
Anticancer drugs and hyperthermia enhance cytotoxicity induced by polyamine enzymatic oxidation products 71
THE ROLE OF COPPER AMINE OXIDASES IN THE METABOLISM OF POLYAMINES AND THEIR THERAPEUTIC IMPLICATIONS 70
Polyamine catabolism: target for antiproliferative therapies in animals and stress tolerance strategies in plants 69
Agmatine transport in brain mitochondria: a different mechanism from that in liver mitochondria 69
A combined structure and ligand-based application on BSAO as an encouraging approach in anti-cancer therapy. 67
Interaction of bovine serum amine oxidase with the polyamine oxidase inactivator MDL 72527 67
Novel Reversible Monoamine Oxidase A Inhibitors: Highly Potent and Selective 3-(1H-Pyrrol-3-yl)-2-oxazolidinones 67
Cytotoxic effect induced by combination of polyamines metabolites and endocannabinoid, anandamide, on human cancer cells: a new anticancer strategy” 63
ADP/ATP exchange by the adenine nucleotide translocase is involved in spermine efflux from energized liver mitochondria. Molecular mechanism and pathophysiological implications 62
A kinetic study of new polyamine analogs oxidized by bovine serum amine oxidase 61
The combined treatment with chloroquine and the enzymatic oxidation products of spermine overcomes multidrug resistance of melanoma M14 ADR2 cells: a new therapeutic approach 61
Effect of peroxides on spermine transport in rat brain and liver mitochondria 57
MDL 72527 and spermine oxidation products induce a lysosomotropic effect and mitochondrial alterations in tumour cells 56
Computational strategies to design new highly potential BSAO polyamine substrates 55
Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments 48
Spermine metabolism and radiation-derived reactive oxygen species for future therapeutic implications in cancer: an additive or adaptive response. 47
“L’aminossidasi purificata dal siero bovino induce un effetto citotossico su cellule tumorali umane, in presenza di poliamine: un nuovo approccio nella terapia antineoplastica” 46
· “Enzymatic spermine metabolites induce cytotoxicity to multidrug resistant human melanoma cells: sensitisation by lysosomotropic compounds. A new therapeutic approach.” 46
Oxidative deamination of new polyamine analogs by bovine serum amine oxidase: a kinetic study 46
HYPERTHERMIA AND SPERMINE ENZYMATIC OXIDATION PRODUCTS INDUCE CYTOTOXICITY ON HUMAN CANCER CELLS. 45
Interactions between new polyamine analogs and bovine serum amine oxidase. 45
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. 45
SPERMINE ENZYMATIC OXIDATION PRODUCTS INDUCE MITOCHONDRIAL PERMEABILITY TRANSITION IN RAT LIVER AND CYTOTOXICITY IN HUMAN CANCER CELLS 44
Bovine serum amine oxidase and spermine in association with anandamide cause cytotoxicity in melanoma and colon adenocarcinoma cells 43
Chloroquine enhances cytotoxicity on human cancer cells induced by polyamines metabolites: Nanotechnology approaches for anticancer agents delivery 40
A comparative study between spermine oxidase and bovine serum amine oxidase in differential scanning calorimetry and on cytotoxicity on cancer cell lines. 40
Polyamine enzymatic oxidation products in cancer therapy : Chloroquine and docetaxel potentiate their cytotoxicity” 39
MDL 72527 POTENTIATES CELL DEATH INDUCED BY SPERMINE OXIDATION PRODUCTS ON HUMAN CANCER CELLS 38
"Chloroquine potentiates cytotoxicity induced by enzymatic spermine metabolites on human cancer cells.” 38
A new chemical compound (EHW 437) enhances the cytotoxic effect of spermine metabolites on human cancer cells 38
I prodotti di ossidazione enzimatica della spermina inducono citotossicità su linee tumorali umane e farmacoresistenti 37
Chloroquine sensitizes human melanoma cells (M14) to the enzymatic oxidation products of spermine 36
Core-shell gold nanoparticles as tool for the delivery of antitumor agents 36
CHLOROQUINE IN ASSOCIATION WITH BSAO/SPERMINE INDUCES ULTRASTUCTURAL ALTERATIONS IN HUMAN TUMOR CELLS: A NEW APPROACH IN CANCER THERAPY 35
Bovine Serim Amine Oxidase immobilized on polymers as new approach in anticancer therapy 35
Chemosensitizer Agents Associated with Polyamine enzymatic oxidation products Enhance apoptosis on MDR human tumour cells. A new approach in cancer therapy” 34
CHLOROQUINE POTENTIATES THE CYTOTOXIC EFFECT INDUCED BY ENZYMATIC OXIDATION PRODUCTS OF SPERMINE ON HUMAN COLON ADENOCARCINOMA LoVo CELLS: A NEW THERAPEUTIC APPROACH 34
MDL 72527 and CQ Potentiate Cytotoxicity of Spermine Enzymatic Oxidation Products on Tumor Cells. 33
Amine oxidase and sprmine induce cytotoxicity on human multidrug-resistant cancer cells 33
“ Enhancement of spermine metabolites cytotoxicity to human cancer cells by lisosomotropic compounds. A new therapeutic approach” 32
Chloroquine Potentiates Cytotoxicity of Spermine Oxidation Products on Human Cancer Cells 31
Amine oxidases and spermine induce greater cytotoxicity in melanoma cells (M14) than in melanocytes 30
CYTOTOXICITY INDUCED ON HUMAN MELANOMA CELLS (M14) BY ENZYMATIC OXIDATION PRODUCTS OF SPERMINE IS POTENTIATED BY CHLOROQUINE, A LYSOSOMOTROPIC COMPOUNDS. 30
“Chloroquine and hyperthermia enhance toxicity induced by spermine metabolite on human cancer cells” 30
“MDL 72527 and chloroquine potentiate cell death induced by enzymatic oxidation products of spermine on human cancer cells.” 29
The combined treatment with chloroquine and BSAO/spermine overcomes multidrug resistance of colon adenocarcinoma cells (LoVo): a new therapeutic approach 29
Spermine enzymatic oxidation products in cancer therapy: Lysosomotropic compounds and docetaxel potentiate their cytotoxicity 29
Spermine enzymatic oxidation products alone and in association with anandamide induce cytotoxicity in human cancer cells 29
Lysosomotropic compounds and Docetaxel sensitize cancer cells to enzymatic spermine metabolites. A new approach in tumour therapy 28
“Lysosomotropic compounds and polyamine oxidation products in cancer therapy” 27
lysosomotropic compounds sensitize human melanoma cells (M14) to the enzymatic oxidation products of spermine 26
MITOCHONDRIAL ALTERATIONS INDUCED BY BOVINE SERUM AMINE OXIDASE AND SPERMINE ON HUMAN MULTIDRUG RESISTANT MELANOMA CELLS 25
“Improvement of spermine enzymatic oxidation products toxicity to human cancer cells by the polyamines oxidase inactivator chloroquine and MDL 72527” 25
The physiological role of biogenic amines redox reactions in mithocondria. New perspectives in cancer therapy 24
Role of Bsao and of the initiation Factor EIF-5A in the potentiation of apoptosis and growth inhibition induced by interferon alpha in human epidermoid cancer cells 23
MDL 72527, a lysosomotropic compound, enhances the cytotoxic effect of the spermine oxidation products on multidrug resistant melanoma cells 23
Chloroquine(CQ) and the aldehyde piperidine oximether (EHW437)potenziate the cytotoxicity of spermine metabolite on human cancer cells 23
“Potentiation of BSAO/spermine toxicity to multidrug resistano human tumor cells by chloroquine” 21
Lysosomotropic compounds sensitize apoptosis apoptosis in cancer cells caused by spermine metabolites. Use of nanoparticles as delivery system in therapy 21
The mechanism of spermine cycling across the inner mitochondrial membrane and its pathophysiological implications 19
“ Polyamine enzymatic oxidation products in cancer therapy : Chloroquine and docetaxel potentiate their cytotoxicity 18
“The oxidation products of spermine induce cytotoxic effects on cultured tumor cells with multidrug resistant phenotype”. 18
Cytotoxicity of polyamine metabolites induces apoptosis on cells: New approaches in cancer therapy by nanocarriers through proteomic and bioinformatic studies 15
Potentation of cytotoxicity induces apoptosis in tumor cells: new approach in cancer therapy by nanocarriers 14
Totale 2.864
Categoria #
all - tutte 8.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020239 0 0 0 0 0 0 43 47 33 62 42 12
2020/2021216 25 24 7 33 6 17 1 31 23 20 21 8
2021/2022541 6 33 43 8 89 5 4 55 53 62 35 148
2022/2023616 151 110 54 69 76 45 5 29 44 10 19 4
2023/2024241 20 49 9 16 17 29 2 16 1 31 20 31
2024/2025282 25 5 23 5 107 117 0 0 0 0 0 0
Totale 2.864